Related Experiment Videos
[New aspects on the pathogenesis of patent ductus arteriosus in premature infants]
Insights
Vasodilator prostaglandins contribute to persistent ductus arteriosus (PDA) in preterm infants with respiratory distress syndrome (RDS). Mechanical ventilation can trigger a cycle of prostaglandin release, PDA, and continued ventilation, which can be interrupted by treatments.
Area of Science:
- Neonatal physiology
- Cardiovascular research
- Respiratory medicine
Context:
- Persistent ductus arteriosus (PDA) is a common complication in preterm infants with respiratory distress syndrome (RDS).
- Mechanical ventilation, often required for RDS, is implicated in PDA pathogenesis.
- Elevated levels of vasodilator prostaglandins, specifically PGI2 and PGE2, are observed in infants with PDA.
Purpose:
- To elucidate the role of vasodilator prostaglandins in the pathogenesis of PDA in preterm infants.
- To investigate the link between mechanical ventilation and increased prostaglandin synthesis.
- To identify potential therapeutic targets for interrupting the PDA cycle.
Summary:
- Mechanical ventilation in preterm infants with RDS can cause pulmonary stress and barotrauma, leading to the release of vasodilator prostaglandins (PGI2, PGE2).
- These prostaglandins increase blood flow to the ductus arteriosus, exacerbating PDA and necessitating continued ventilation, creating a detrimental cycle.
- Inhibition of prostaglandin synthesis (e.g., with indomethacin) or reduced ventilation can lead to ductal closure.
Impact:
- Understanding this mechanism provides a rationale for therapeutic interventions like indomethacin treatment or optimized ventilation strategies.
- This research may lead to improved management of PDA in preterm neonates, reducing the need for prolonged mechanical ventilation.
- Identifies a critical pathway involving prostaglandins and mechanical ventilation in neonatal cardiovascular complications.
Abstract:
It is generally accepted that vasodilator prostaglandins are involved in the pathogenesis of persistent ductus arteriosus (PDA) in preterm infants suffering from respiratory distress syndrome (RDS). When studying the prostaglandin metabolism it became apparent that in about 80% of these infants the activity of PGI2 and/or PGE2 was increased. In parallel to weaning infants from the respirator a decrease in prostaglandin activity was observed which was associated with ductal closure. The inhibition of prostaglandin synthesis with indomethacin had the same effect. Considering the various lines of evidence that an artificially ventilated lung is releasing vasodilatory prostaglandins into the circulation we postulated the following sequence of events in the pathogenesis of PDA in preterm infants: development of RDS or other pulmonary lesions which require artificial ventilation; this mechanical intervention causes permanent shear stress and barotrauma on the pulmonary tissue; this stress causes release of arachidonic acid from phospholipids; subsequently vasodilatory prostanoids, such as PGI2 and PGE2 are released and reach the pulmonary circulation and the ductus arteriosus. As a consequence the left-to-right shunt causes pulmonary hypercirculation with further need to continue artificial ventilation. A vicious circle is established. This circle can be broken by ductus ligation, by indomethacin treatment, by less traumatic artificial ventilation or by early weaning from the respirator with theophylline.